RE: WOW!!!!!9 Dec 2020 08:58
Took the words out of my mouth skid. A NASDAQ listing will also help, look at today's comments quoted in the Telegraph about Snowflake where income GROWTH is key"A continued surge in Snowflake's shares, which have risen by 242pc since its debut and by as much as 45pc during the last five days of trading, propelled it to a market capitalisation of $116bn (£87bn) yesterday evening on Tuesday evening.
That put the youthful Californian data warehousing service above the 109-year-old IBM, worth $112bn, as well as the chipmaker AMD, worth $111bn.
Although Snowflake does not make a profit, and although its projected annual revenue of $578m is many times lower than IBM's $74bn, investors were excited by its rapid year on year income growth of 119pc.
Responding to Snowflake's first financial results last week, Deutsche Bank analyst Patrick Colville told Bloomberg: “This growth is suggestive of a very large total addressable market and clear product market fit."
Well from Opti's half year report "The first six months of this year has seen strong revenue growth with a 400% increase in group income and individual divisions reporting a 1,309% (SlimBiome®) and 477% (LPLDL®) increase in revenues. This was achieved against a 15.5% reduction in other administration costs and a 50% reduction in the loss compared to the same period last year. The strong sales growth is especially pleasing given the uncertain global economic environment and impact on potential sales as a result of COVID-19, particularly in countries like India and the USA, in the first six months of the year. Whilst these percentage increases are compared to a low base, there is an acceleration in year-on-year revenue growth as more agreements generate revenues, existing partners grow sales, and more retail partners launch products. The Company is now at a commercial turning point with a proven business model, growing sales from proven products, partners in multiple international territories, and reduced administration and R&D costs. This places the Company in a strong position to exploit the opportunity in the global human microbiome market expected to show a CAGR of 22.60% between 2020 and 2025 (Mordor Intelligence 2019)."
Sign In
Follow the stocks
